Short Interest in NanoVibronix, Inc. (NASDAQ:NAOV) Decreases By 85.5%

NanoVibronix, Inc. (NASDAQ:NAOV) was the target of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 38,700 shares, a drop of 85.5% from the February 28th total of 267,600 shares. Currently, 4.9% of the company’s shares are sold short. Based on an average daily volume of 994,800 shares, the days-to-cover ratio is currently 0.0 days.

NanoVibronix Price Performance

NanoVibronix stock traded down $0.04 during midday trading on Thursday, reaching $3.86. The stock had a trading volume of 7,267 shares, compared to its average volume of 268,464. NanoVibronix has a twelve month low of $1.92 and a twelve month high of $13.97. The firm’s fifty day simple moving average is $4.37 and its two-hundred day simple moving average is $5.93. The firm has a market cap of $3.05 million, a price-to-earnings ratio of -3.13 and a beta of 1.81.

About NanoVibronix

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.